Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs.

Shigayeva A, Rudnick W, Green K, Chen DK, Demczuk W, Gold WL, Johnstone J, Kitai I, Krajden S, Lovinsky R, Muller M, Powis J, Rau N, Walmsley S, Tyrrell G, Bitnun A, McGeer A; Toronto Invasive Bacterial Diseases Network.

Clin Infect Dis. 2016 Jan 15;62(2):139-47. doi: 10.1093/cid/civ803. Epub 2015 Sep 9.

PMID:
26354970
2.

Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections.

Claeys KC, Smith JR, Casapao AM, Mynatt RP, Avery L, Shroff A, Yamamura D, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2015 Apr;59(4):1969-76. doi: 10.1128/AAC.04141-14. Epub 2015 Jan 20.

3.

Characterization of methicillin-resistant Staphylococcus aureus isolates from patients with persistent or recurrent bacteremia.

Wong H, Watt C, Elsayed S, John M, Johnson G, Katz K, Krajden S, Lee C, Mazzulli T, Ostrowska K, Richardson D, Toye B, Vermeiren C, Yamamura D, Simor AE.

Can J Infect Dis Med Microbiol. 2014 Mar;25(2):83-6.

4.

Clinical and tree hollow populations of human pathogenic yeast in Hamilton, Ontario, Canada are different.

Carvalho C, Yang J, Vogan A, Maganti H, Yamamura D, Xu J.

Mycoses. 2014 May;57(5):271-83. doi: 10.1111/myc.12156. Epub 2013 Nov 28.

PMID:
24283796
5.

Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.

Rudnick W, Liu Z, Shigayeva A, Low DE, Green K, Plevneshi A, Devlin R, Downey J, Katz K, Kitai I, Krajden S, Ostrowska K, Richardson D, Richardson S, Sarabia A, Silverman M, Simor AE, Tyrrell G, McGeer A; Toronto Invasive Bacterial Diseases Network.

Vaccine. 2013 Dec 2;31(49):5863-71. doi: 10.1016/j.vaccine.2013.09.049. Epub 2013 Oct 5.

PMID:
24099873
6.

Inappropriate use of antibiotics and Clostridium difficile infection.

Srigley JA, Brooks A, Sung M, Yamamura D, Haider S, Mertz D.

Am J Infect Control. 2013 Nov;41(11):1116-8. doi: 10.1016/j.ajic.2013.04.017. Epub 2013 Aug 7.

PMID:
23932828
7.

Daptomycin-nonsusceptible, vancomycin-intermediate, methicillin-resistant Staphylococcus aureus endocarditis.

Yu R, Dale SE, Yamamura D, Stankus V, Lee C.

Can J Infect Dis Med Microbiol. 2012 Summer;23(2):e48-50.

8.

Evaluation of coseasonality of influenza and invasive pneumococcal disease: results from prospective surveillance.

Kuster SP, Tuite AR, Kwong JC, McGeer A; Toronto Invasive Bacterial Diseases Network Investigators, Fisman DN.

PLoS Med. 2011 Jun;8(6):e1001042. doi: 10.1371/journal.pmed.1001042. Epub 2011 Jun 7.

9.

Susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada.

Patel SN, McGeer A, Melano R, Tyrrell GJ, Green K, Pillai DR, Low DE; Canadian Bacterial Surveillance Network.

Antimicrob Agents Chemother. 2011 Aug;55(8):3703-8. doi: 10.1128/AAC.00237-11. Epub 2011 May 31.

10.

Prevalent nosocomial clusters among causative agents for candidemia in Hamilton, Canada.

Maganti H, Yamamura D, Xu J.

Med Mycol. 2011 Jul;49(5):530-8. doi: 10.3109/13693786.2010.547880. Epub 2011 Jan 3.

PMID:
21198348
11.

Should my patient with inflammatory bowel disease on immunosuppressive therapy be vaccinated against influenza virus?

Narula N, Yamamura DL, Marshall JK.

Can J Gastroenterol. 2010 Feb;24(2):121-5. Review.

12.

Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto.

Plevneshi A, Svoboda T, Armstrong I, Tyrrell GJ, Miranda A, Green K, Low D, McGeer A; Toronto Invasive Bacterial Diseases Network.

PLoS One. 2009 Sep 29;4(9):e7255. doi: 10.1371/journal.pone.0007255.

13.

Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance.

Kumar D, Humar A, Plevneshi A, Siegal D, Franke N, Green K, McGeer A; Toronto Invasive Bacterial Diseases Network.

Bone Marrow Transplant. 2008 Apr;41(8):743-7. doi: 10.1038/sj.bmt.1705964. Epub 2008 Jan 7.

PMID:
18176614
14.

One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome.

Tansey CM, Louie M, Loeb M, Gold WL, Muller MP, de Jager J, Cameron JI, Tomlinson G, Mazzulli T, Walmsley SL, Rachlis AR, Mederski BD, Silverman M, Shainhouse Z, Ephtimios IE, Avendano M, Downey J, Styra R, Yamamura D, Gerson M, Stanbrook MB, Marras TK, Phillips EJ, Zamel N, Richardson SE, Slutsky AS, Herridge MS.

Arch Intern Med. 2007 Jun 25;167(12):1312-20.

PMID:
17592106
15.

Rat-bite fever, Canada.

Schachter ME, Wilcox L, Rau N, Yamamura D, Brown S, Lee CH.

Emerg Infect Dis. 2006 Aug;12(8):1301-2. No abstract available.

16.

Short report: Ceftriaxone for cat and dog bites. Simple outpatient treatment.

Pennie RA, Szakacs TA, Smaill FM, Smieja M, Yamamura D, McTaggart B, McCallum A.

Can Fam Physician. 2004 Apr;50:577-9. No abstract available.

17.

A semiquantitative stool antigen test for Helicobacter pylori: shedding new light?

Marshall JK, Yamamura DL.

J Clin Gastroenterol. 2002 Nov-Dec;35(5):369-70. No abstract available.

PMID:
12394221
18.

Use and misuse of cost-effectiveness terminology in the gastroenterology literature: a systematic review.

Marshall JK, Cawdron R, Yamamura DL, Ganguli S, Lad R, O'Brien BJ.

Am J Gastroenterol. 2002 Jan;97(1):172-9. Review.

PMID:
11811165
20.

Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients.

Yamamura D, Gucalp R, Carlisle P, Cimino M, Roberts J, Rotstein C.

Antimicrob Agents Chemother. 1997 Aug;41(8):1704-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk